Edatrexate [10 EDAM] shows relatively moderate activity in the treatment of metastatic breast cancer, but is well tolerated

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1596, 2007-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegylated liposomal doxorubicin is active and well tolerated in elderly women with metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Concurrent treatment with epirubicin, docetaxel and cisplatin shows activity in metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Capecitabine monotherapy is an effective and well tolerated first-line treatment for patients with advanced or metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

High-dose chemotherapy regimen well tolerated in breast cancer

By  

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Docetaxel plus cisplatin: active and well tolerated in locally advanced or metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite